Tricor Générique est utilisé pour contrôler les niveaux élevés de cholestérol et de triglycérides dans le sang. Il est utilisé en combinaison avec une alimentation faible en cholestérol et en graisses saturées. Le Tricor Générique est un agent régulateur de lipides. Il diminue les niveaux élevés de triglycérides dans le sang en poussant le foie à produire moins de triglycérides et à éliminer plus de triglycérides de la circulation sanguine.
Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)
Treatment of chronic hemodialysis patients with low-dose fenofibrate .
Impax cited by FDA in manufacturing inspection - FierceDrugDelivery
Impax cited by FDA in manufacturing inspectionFierceDrugDeliveryThe company was cited last year for issues related to the production of fenofibrate, a high cholesterol treatment, resulting in a recall of 5 lots of the drug, FiercePharmaManufacturing reported.
Expect strong growth from US in FY13-14 - Moneycontrol.com
Expect strong growth from US in FY13-14Moneycontrol.
Veloxis Restructures to Focus on Late-Stage Once-Daily Immunosuppressant - Genetic Engineering News
Veloxis Restructures to Focus on Late-Stage Once-Daily ImmunosuppressantGenetic Engineering NewsApart from LCP-Tacro, the firm's clinical pipeline includes the Phase II- and III-ready cardiovascular products AtorFen™, a fixed-dose combination tablet of fenofibrate and atorvastatin, and LCP-Feno™, a generic fenofibrate tablet formulation.
Webcast - Q1 Earnings AnnouncementCanada NewsWire (press release)The Company's first product is a fenofibrate formulation marketed in the United States as Lipofen®.